A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma

Meser M. Ali, Mohammed P.I. Bhuiyan, Branislava Janic, Nadimpalli R.S. Varma, Tom Mikkelsen, James R. Ewing, Robert A. Knight, Mark D. Pagel, Ali Syed Arbab

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Aim: The authors have investigated the usefulness of in vivo chemical exchange saturation transfer MRI for detecting gliomas using a dual-modality imaging contrast agent. Materials & methods: A paramagnetic chemical exchange saturation transfer MRI contrast agent, Eu-1,4,7,10- tetraazacclododecane-1,4,7,10-tetraacetic acid-Gly4 and a fluorescent agent, DyLight® 680, were conjugated to a generation 5 polyamidoamine dendrimer to create the dual-modality, nano-sized imaging contrast agent. Results: The agent was detected with in vivo chemical exchange saturation transfer MRI in an U87 glioma model. These results were validated using in vivo and ex vivo fluorescence imaging. Conclusion: This study demonstrated the merits of using a nano-sized imaging contrast agent for detecting gliomas and using a dual-modality agent for detecting gliomas at different spatial scales. Original submitted 9 January 2012; Revised submitted 18 April 2012; Published online 14 August 201.

Original languageEnglish (US)
Pages (from-to)1827-1837
Number of pages11
JournalNanomedicine
Volume7
Issue number12
DOIs
StatePublished - Dec 1 2012
Externally publishedYes

Fingerprint

Optical Imaging
Glioma
Magnetic resonance imaging
Contrast Media
Fluorescence
Imaging techniques
Dendrimers
Fluorescent Dyes
Acids

Keywords

  • MRI
  • brain tumor
  • contrast agent
  • dendrimer
  • pharmacokinetic

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • Materials Science(all)

Cite this

A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma. / Ali, Meser M.; Bhuiyan, Mohammed P.I.; Janic, Branislava; Varma, Nadimpalli R.S.; Mikkelsen, Tom; Ewing, James R.; Knight, Robert A.; Pagel, Mark D.; Arbab, Ali Syed.

In: Nanomedicine, Vol. 7, No. 12, 01.12.2012, p. 1827-1837.

Research output: Contribution to journalArticle

Ali, MM, Bhuiyan, MPI, Janic, B, Varma, NRS, Mikkelsen, T, Ewing, JR, Knight, RA, Pagel, MD & Arbab, AS 2012, 'A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma', Nanomedicine, vol. 7, no. 12, pp. 1827-1837. https://doi.org/10.2217/nnm.12.92
Ali, Meser M. ; Bhuiyan, Mohammed P.I. ; Janic, Branislava ; Varma, Nadimpalli R.S. ; Mikkelsen, Tom ; Ewing, James R. ; Knight, Robert A. ; Pagel, Mark D. ; Arbab, Ali Syed. / A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma. In: Nanomedicine. 2012 ; Vol. 7, No. 12. pp. 1827-1837.
@article{776fe1d5a3d34cbfb4146e2385304a24,
title = "A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma",
abstract = "Aim: The authors have investigated the usefulness of in vivo chemical exchange saturation transfer MRI for detecting gliomas using a dual-modality imaging contrast agent. Materials & methods: A paramagnetic chemical exchange saturation transfer MRI contrast agent, Eu-1,4,7,10- tetraazacclododecane-1,4,7,10-tetraacetic acid-Gly4 and a fluorescent agent, DyLight{\circledR} 680, were conjugated to a generation 5 polyamidoamine dendrimer to create the dual-modality, nano-sized imaging contrast agent. Results: The agent was detected with in vivo chemical exchange saturation transfer MRI in an U87 glioma model. These results were validated using in vivo and ex vivo fluorescence imaging. Conclusion: This study demonstrated the merits of using a nano-sized imaging contrast agent for detecting gliomas and using a dual-modality agent for detecting gliomas at different spatial scales. Original submitted 9 January 2012; Revised submitted 18 April 2012; Published online 14 August 201.",
keywords = "MRI, brain tumor, contrast agent, dendrimer, pharmacokinetic",
author = "Ali, {Meser M.} and Bhuiyan, {Mohammed P.I.} and Branislava Janic and Varma, {Nadimpalli R.S.} and Tom Mikkelsen and Ewing, {James R.} and Knight, {Robert A.} and Pagel, {Mark D.} and Arbab, {Ali Syed}",
year = "2012",
month = "12",
day = "1",
doi = "10.2217/nnm.12.92",
language = "English (US)",
volume = "7",
pages = "1827--1837",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine Ltd.",
number = "12",

}

TY - JOUR

T1 - A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma

AU - Ali, Meser M.

AU - Bhuiyan, Mohammed P.I.

AU - Janic, Branislava

AU - Varma, Nadimpalli R.S.

AU - Mikkelsen, Tom

AU - Ewing, James R.

AU - Knight, Robert A.

AU - Pagel, Mark D.

AU - Arbab, Ali Syed

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Aim: The authors have investigated the usefulness of in vivo chemical exchange saturation transfer MRI for detecting gliomas using a dual-modality imaging contrast agent. Materials & methods: A paramagnetic chemical exchange saturation transfer MRI contrast agent, Eu-1,4,7,10- tetraazacclododecane-1,4,7,10-tetraacetic acid-Gly4 and a fluorescent agent, DyLight® 680, were conjugated to a generation 5 polyamidoamine dendrimer to create the dual-modality, nano-sized imaging contrast agent. Results: The agent was detected with in vivo chemical exchange saturation transfer MRI in an U87 glioma model. These results were validated using in vivo and ex vivo fluorescence imaging. Conclusion: This study demonstrated the merits of using a nano-sized imaging contrast agent for detecting gliomas and using a dual-modality agent for detecting gliomas at different spatial scales. Original submitted 9 January 2012; Revised submitted 18 April 2012; Published online 14 August 201.

AB - Aim: The authors have investigated the usefulness of in vivo chemical exchange saturation transfer MRI for detecting gliomas using a dual-modality imaging contrast agent. Materials & methods: A paramagnetic chemical exchange saturation transfer MRI contrast agent, Eu-1,4,7,10- tetraazacclododecane-1,4,7,10-tetraacetic acid-Gly4 and a fluorescent agent, DyLight® 680, were conjugated to a generation 5 polyamidoamine dendrimer to create the dual-modality, nano-sized imaging contrast agent. Results: The agent was detected with in vivo chemical exchange saturation transfer MRI in an U87 glioma model. These results were validated using in vivo and ex vivo fluorescence imaging. Conclusion: This study demonstrated the merits of using a nano-sized imaging contrast agent for detecting gliomas and using a dual-modality agent for detecting gliomas at different spatial scales. Original submitted 9 January 2012; Revised submitted 18 April 2012; Published online 14 August 201.

KW - MRI

KW - brain tumor

KW - contrast agent

KW - dendrimer

KW - pharmacokinetic

UR - http://www.scopus.com/inward/record.url?scp=84871324512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871324512&partnerID=8YFLogxK

U2 - 10.2217/nnm.12.92

DO - 10.2217/nnm.12.92

M3 - Article

C2 - 22891866

AN - SCOPUS:84871324512

VL - 7

SP - 1827

EP - 1837

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 12

ER -